MUCOPOLYSACCHARIDOSIS VI
Clinical trials for MUCOPOLYSACCHARIDOSIS VI explained in plain language.
Never miss a new study
Get alerted when new MUCOPOLYSACCHARIDOSIS VI trials appear
Sign up with your email to follow new studies for MUCOPOLYSACCHARIDOSIS VI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for easing debilitating pain in rare genetic diseases
Symptom relief OngoingThis study is testing whether a medication called adalimumab can help reduce joint pain and improve movement in children and adults with mucopolysaccharidosis (MPS) types I, II, or VI. These are rare genetic disorders that cause severe joint stiffness and pain. For the first 16 w…
Matched conditions: MUCOPOLYSACCHARIDOSIS VI
Phase: PHASE1, PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Massive study screens 100,000 babies for hidden rare diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to gather information by offering expanded newborn screening to 100,000 babies in New York. It will test for 14 rare genetic disorders to see how accurate the tests are, how often these diseases occur, and if finding them early helps children's health. The main go…
Matched conditions: MUCOPOLYSACCHARIDOSIS VI
Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC